C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin

International Journal of Colorectal Disease

Volumn 26, Issue 8, 2011, Pages 1067-1073

  Van De Poll, Marcel C G ^a   Klaver, Yvonne L B ^a   Lemmens, Valery E P P ^b   Leenders, Bart J M ^a   Nienhuijs, Simon W ^a   De Hingh, Ignace H J T ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b The Netherlands   (Netherlands)

Author keywords

C reactive protein; Chemotherapy; Inflammation; Outcome; Peritoneal carcinomatosis; Survival

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL RECORD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

AGED; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PERITONEAL NEOPLASMS; PROGNOSIS;

EID: 80051596783     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-011-1187-7     Document Type: Article

References (26)

1. DZ Chu NP Lang C Thompson PK Osteen KC Westbrook 1989 Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors Cancer 63 364 367 2910444 10.1002/1097-0142(19890115)63:2<364::AID- CNCR2820630228>3.0.CO;2-V 1:STN:280:DyaL1M%2FovFGnsQ%3D%3D (Pubitemid 19035034)
2. VJ Verwaal S Bruin H Boot G van Slooten H van Tinteren 2008 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer Ann Surg Oncol 15 2426 2432 18521686 10.1245/s10434-008-9966-2
3. MJ Koppe OC Boerman WJ Oyen RP Bleichrodt 2006 Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies Ann Surg 243 212 222 16432354 10.1097/01.sla.0000197702.46394.16 (Pubitemid 43185440)
4. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual. Springer, New York
5. H Ueno H Mochizuki Y Hashiguchi M Ishiguro Y Kajiwara T Sato H Shimazaki K Hase IC Talbot 2008 Histological grading of colorectal cancer: a simple and objective method Ann Surg 247 811 818 18438118 10.1097/SLA.0b013e318167580f (Pubitemid 351591516)
6. R Takagawa S Fujii M Ohta Y Nagano C Kunisaki S Yamagishi S Osada Y Ichikawa H Shimada 2008 Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer Ann Surg Oncol 15 3433 3439 18846401 10.1245/s10434-008-0168-8
7. M Ishizuka H Nagata K Takagi K Kubota 2009 Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer Ann Surg 250 268 272 19638907 10.1097/SLA.0b013e3181b16e24
8. M Zacharakis ID Xynos A Lazaris T Smaro C Kosmas A Dokou E Felekouras E Antoniou A Polyzos J Sarantonis J Syrios G Zografos, et al. 2010 Predictors of survival in stage IV metastatic colorectal cancer Anticancer Res 30 653 660 20332485 1:CAS:528:DC%2BC3cXksFCqtrw%3D
9. Y Koike C Miki Y Okugawa T Yokoe Y Toiyama K Tanaka Y Inoue M Kusunoki 2008 Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer J Surg Oncol 98 540 544 18937231 10.1002/jso.21154 1:CAS:528:DC%2BD1MXmtVSguw%3D%3D
10. T Nozoe E Mori I Takahashi T Ezaki 2008 Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma Surg Today 38 597 602 18612783 10.1007/s00595-007-3680-8 1:CAS:528:DC%2BD1cXosVOgtLw%3D (Pubitemid 351977653)
11. JE Crozier RF McKee CS McArdle WJ Angerson JH Anderson PG Horgan DC McMillan 2007 Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer Br J Surg 94 1028 1032 17437250 10.1002/bjs.5706 1:CAS:528:DC%2BD2sXhtVemtbbI (Pubitemid 47236550)
12. YC Shiu JK Lin CJ Huang JK Jiang LW Wang HC Huang SH Yang 2008 Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum 51 443 449 18172726 10.1007/s10350-007-9133-z
13. LM Forrest DC McMillan CS McArdle WJ Angerson DJ Dunlop 2003 Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer Br J Cancer 89 1028 1030 12966420 10.1038/sj.bjc.6601242 1:STN:280:DC%2BD3svisVOjsg%3D%3D (Pubitemid 37239206)
14. B Gagnon M Abrahamowicz Y Xiao ME Beauchamp N MacDonald G Kasymjanova H Kreisman D Small 2010 Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer Br J Canc 102 1113 1122 10.1038/sj.bjc.6605603 1:CAS:528:DC%2BC3cXjvFymtro%3D
15. JK Pine KG Fusai R Young D Sharma BR Davidson KV Menon SH Rahman 2009 Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas Eur J Surg Oncol 35 605 610 19128923 1:STN:280:DC%2BD1MzhsVCltQ%3D%3D
16. SD Khandavilli PO Ceallaigh CJ Lloyd R Whitaker 2009 Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma Oral Oncol 45 912 914 19502100 10.1016/j.oraloncology.2009.03.015 1:CAS:528:DC%2BD1MXhtFGnsb7P
17. BL Pierce R Ballard-Barbash L Bernstein RN Baumgartner ML Neuhouser MH Wener KB Baumgartner FD Gilliland BE Sorensen A McTiernan CM Ulrich 2009 Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients J Clin Oncol 27 3437 3444 19470939 10.1200/JCO.2008.18. 9068 1:CAS:528:DC%2BD1MXhtVSqtLvE
18. T Vainas FR Stassen R de Graaf EL Twiss SB Herngreen RJ Welten LH van den Akker MP van Dieijen-Visser CA Bruggeman PJ Kitslaar 2005 C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events J Vasc Surg 42 243 251 16102622 10.1016/j.jvs.2005.03.060 (Pubitemid 41139229)
19. FM van Dielen WA Buurman M Hadfoune J Nijhuis JW Greve 2004 Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery J Clin Endocrinol Metab 89 4062 4068 15292349 10.1210/jc.2003-032125 (Pubitemid 39071514)
20. MM Moore W Chua KA Charles SJ Clarke 2010 Inflammation and cancer: causes and consequences Clin Pharmacol Ther 87 504 508 20147899 10.1038/clpt.2009.254 1:CAS:528:DC%2BC3cXjs1ajtrs%3D
21. AG Moses J Maingay K Sangster KC Fearon JA Ross 2009 Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival Oncol Rep 21 1091 1095 19288013 1:CAS:528:DC%2BD1MXksVSrtbs%3D
22. SJ Wigmore DN Redhead XJ Yan J Casey K Madhavan CH Dejong EJ Currie OJ Garden 2001 Virtual hepatic resection using three-dimensional reconstruction of helical computed tomography angioportograms Ann Surg 233 221 226 11176128 10.1097/00000658-200102000-00011 1:STN:280:DC%2BD3M7ls1SmsA%3D%3D (Pubitemid 32106076)
23. MC van de Poll SJ Wigmore DN Redhead RG Beets-Tan OJ Garden JW Greve PB Soeters NE Deutz KC Fearon CH Dejong 2007 Effect of major liver resection on hepatic ureagenesis in humans Am J Physiol 293 G956 G962 10.1152/ajprenal.00090. 2007 (Pubitemid 47403368)
24. MI Koukourakis G Kambouromiti D Pitsiava P Tsousou M Tsiarkatsi G Kartalis 2009 Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication Inflammation 32 169 175 19373547 10.1007/s10753-009-9116-4 1:CAS:528: DC%2BD1MXlvV2gsr4%3D
25. JE Crozier DC McMillan CS McArdle WJ Angerson JH Anderson PG Horgan RF McKee 2007 Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer J Gastroenterol Hepatol 22 2288 2291 18031394 10.1111/j.1440-1746.2006.04792.x (Pubitemid 350145619)
26. N Damjanov J Weiss DG Haller 2009 Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease Oncologist 14 963 969 19819916 10.1634/theoncologist.2009-0022